Some N.J. private schools for disabled students cashing in on taxpayers

[proverbialwisdom]

19. Thanks for the links, though I won't read them until after the holiday. Save these for later, too.

The field is rapidly evolving. In part, VICP hearings will clarify matters. Meanwhile, see the IACC Workshop in its entirety and Drs. Mumper and Herbert in NAJMS.

http://www.ebcala.org/areas-of-law/vaccine-law/chairman-issa-postpones-vicp-hearing
http://digitalcommons.pace.edu/pelr/vol28/iss2/6/

http://www.scribd.com/doc/115393658/Andrew-Zimmerman

Andrew Zimmerman / Poling v HHS Exhibit 3

Published by Heather Rhodes White

In a second case Zimmerman was called to give his expert report on was Poling v. HHS. He revised his testimony, which was in complete contradiction from Cedillo v. HHS. His report to the Special Masters;

“The cause for regressive encephalopathy in Hannah (Poling) at age 19 months was underlying mitochondrial dysfunction, exacerbated by vaccine-induced fever and immune stimulation that exceeded metabolic energy reserves. This acute expenditure of metabolic reserves led to permanent irreversible brain injury. Thus, if not for this event, Hannah may have led a normal full productive life. Presently, I predict Hannah will have a normal lifespan but with significant lifelong disability.”

http://videocast.nih.gov/summary.asp?Live=13225

Air date: Friday, November 15, 2013, 8:45:00 AM
Time displayed is Eastern Time, Washington DC Local

Category: Interagency Autism Coordinating Committee
Runtime: 07:33:03

Description: The workshop will feature discussions between IACC members and external subject matter and community experts regarding updates from the field and from the community that the committee may consider when developing the 2013 update of the IACC Strategic Plan.

http://najms.net/wp-content/uploads/v06i03.pdf#page=34

Preface to the special issue of autism

Autism spectrum disorder (ASD), the fastest-growing complex neurodevelopment disorder, continues to rise in its prevalence, now affecting up to 1 in 50 children in the USA, and averaging 1% globally, according to the latest CDC report. More children will be diagnosed with ASD this year than with AIDS, diabetes & cancer combined in the USA. ASD costs the nation $137 billion a year and this debt is expected to increase in the next decade. Hence, ASD has become a huge healthcare burden and global threat, categorized by the CDC as a national public health crisis.

ASD is characterized by social-communication impairment, and restricted, repetitive, and stereotyped patterns of behavior, which cause significant disability for those affected. With its etiology still largely unknown, and its pathophysiology poorly understood, ASD currently has no universally accepted therapy. ASD is affecting more and more families; unmet services and limited resources need to be addressed urgently. Researchers, clinicians, healthcare providers, social agencies and government need to coordinate efforts to develop more effective treatments and a satisfactory continuum of care, across the lifespan. Ultimately, a cure needs to be sought for the various subtypes of ASD that exist.

The current issue of North American Journal of Medicine and Science (NAJMS) represents a continuation of our previous two special issues on autism (NAJMS Vol. 5 Issue 3 and Vol. 4 Issue 3) published in July 2012 and July 2011, respectively. In this issue, we are honored to have another panel of expert researchers and clinicians on the frontlines of ASD research and treatment to present their newest research findings and views from different perspectives.

This issue of NAJMS consists of five original research articles, two comprehensive reviews, one case report and two commentary articles, covering topics in genetics, pathogenesis, metabolic disorder biomarkers of ASD, and a clinical study, that bring into focus our newest understanding and treatment strategies.

<>

The data presented in Dr. Mumper’s review of the medical literature, suggests that ASD may be impacted by environmental toxicants, duration of breastfeeding, gut flora composition, nutritional status, acetaminophen use, vaccine practices and use of antibiotics and/or frequency of infections. In her current general pediatric practice (Advocates for Children), she has noted a modest trend toward a lower prevalence of ASD than in her previous pediatric practice or recent prevalence estimates from the CDC.

<>

The final commentary was written by Dr. Herbert, who presents her paper entitled “Everyday Epigenetics from Molecular Intervention to Public Health and Lifestyle Medicine.” She asserts that it may well take a grass roots epigenetic/lifestyle medicine revolution to avert the worsening health trends we are facing in the setting of a progressively more toxic and endangered planet. She posits that everyday epigenetics can inform science of what is possible so that society can respond on an appropriate scale to the magnitude of the crisis we are facing.

<>

Xuejun Kong, MD
Editor-in-Chief, NAJMS
Department of Medicine
Beth Israel Deaconess Medical Center
Harvard Medical School

Christopher J. McDougle, MD
Guest Editor, NAJMS
Lurie Center for Autism Massachusetts General Hospital
Harvard Medical School

http://www.democraticunderground.com/101672031